Gil Schwartzberg

2022

In 2022, Gil Schwartzberg earned a total compensation of $80K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 92% decrease compared to previous year.

Compensation breakdown

Option Awards$63,340
Other$16,630
Total$79,970

Schwartzberg received $63.3K in option awards, accounting for 79% of the total pay in 2022.

Schwartzberg also received $16.6K in other compensation.

Rankings

In 2022, Gil Schwartzberg's compensation ranked 5,636th out of 5,756 executives tracked by ExecPay. In other words, Schwartzberg earned more than 2.1% of executives.

ClassificationRankingPercentile
All
5,636
out of 5,756
2nd
Division
Manufacturing
3,075
out of 3,133
2nd
Major group
Chemicals And Allied Products
1,397
out of 1,419
2nd
Industry group
Drugs
1,302
out of 1,320
1st
Industry
Pharmaceutical Preparations
951
out of 966
2nd
Source: SEC filing on November 4, 2024.

Schwartzberg's colleagues

We found six more compensation records of executives who worked with Gil Schwartzberg at LIXTE BIOTECHNOLOGY HOLDINGS in 2022.

2022

Bas der Baan

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2022

René Bernards

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2022

Yun Yen

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2022

Regina Brown

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2022

Stephen Forman

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2022

Philip Palmedo

LIXTE BIOTECHNOLOGY HOLDINGS

Director

In-depth

You may also like